Medifast Inc Revenue Growth Rates (MED), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Medifast Inc   (NYSE: MED)
 

MED's Revenue Growth by Quarter and Year

Medifast Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MED/growth
https://api.csimarket.com/api/v1/companies/MED/fundamentals
https://api.csimarket.com/api/v1/companies/MED/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
MED Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 72.05
2nd Quarter June 76.38
1st Quarter March 75.76
FY 224.19

MEDs Annual Revenue
Medifast Inc 's Revenue in the fiscal year 2025 $ 385.19 millions
Medifast Inc 's Revenue in the fiscal year 2024 $ 601.62 millions
Medifast Inc 's Revenue in the fiscal year 2023 $ 1,071.85 millions
Medifast Inc 's Revenue in the fiscal year 2022 $ 1,598.58 millions
Medifast Inc 's Revenue in the fiscal year 2021 $ 1,526.09 millions




MED Revenue third quarter 2026 Y/Y Growth Comment
Medifast Inc reported decline in Revenue in the third quarter 2026 by -19.19% to $ 72.05 millions, from the same quarter in 2025.
The contraction in the third quarter 2026 Medifast Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 6.66%.

Looking into third quarter 2026 results within Food Processing industry 43 other companies have achieved higher Revenue growth. While Medifast Inc ' s Revenue fall of -19.19% ranks overall at the positon no. 3608 in the third quarter 2026.


MED Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -19.19 %
2nd Quarter June -27.01 %
1st Quarter March -34.26 %
FY   -

Financial Statements
Medifast Inc 's third quarter 2026 Revenue $ 72.05 millions MED's Income Statement
Medifast Inc 's third quarter 2025 Revenue $ 89.16 millions Quarterly MED's Income Statement


MED Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -5.67 %
2nd Quarter June 0.82 %
1st Quarter March 0.88 %
FY (Year on Year)   -


Back to MED Growth rate Comparisons >> Back to MED Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Food Processing Industry #44
Consumer Non Cyclical Sector #145
Overall #3608

Revenue Y/Y Growth Statistics
High Average Low
90.89 % 6.66 % -50.06 %
(Mar 31 2019)   (Sep 30 2024)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Food Processing Industry #44
Consumer Non Cyclical Sector #145
Overall #3608
Revenue Y/Y Growth Statistics
High Average Low
90.89 % 6.66 % -50.06 %
(Mar 31 2019)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Medifast Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
67.19 % -0.7 % -100 %
(Mar 31 2015)  


MED's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Medifast Inc disclosed decline in Revenue from the second quarter by -5.67% to $ 72.05 millions, from $ 76.38 millions achived in the previous reporting period.

But that's not important problem, as Medifast Inc 's Revenue generally seem to plunge in this quarter.

Within Food Processing industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Medifast Inc 's Revenue growth quarter on quarter, overall rank is 1662.


Revenue Q/Q Growth Company Ranking
Within: No.
Food Processing Industry #10
Consumer Non Cyclical Sector #56
Overall #1662
Revenue Q/Q Growth Company Ranking
Within: No.
Food Processing Industry #10
Consumer Non Cyclical Sector #56
Overall #1662
Revenue Q/Q Growth Statistics
High Average Low
67.19 % -0.7 % -100 %
(Mar 31 2015)  


MED's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Medifast Inc disclosed decline in Revenue from the second quarter by -5.67% to $ 72.05 millions, from $ 76.38 millions achived in the previous reporting period.

But that's not important problem, as Medifast Inc 's Revenue generally seem to plunge in this quarter.

Within Food Processing industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Medifast Inc 's Revenue growth quarter on quarter, overall rank is 1662.


Medifast Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 299.28
Y / Y Revenue Growth (TTM) -30.08 %
Year on Year Revenue Growth Overall Ranking # 3560
Seqeuential Revenue Change (TTM) -5.41 %
Seq. Revenue Growth (TTM) Overall Ranking # 3245


Cumulative Revenue growth Comment
Medifast Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2026. If the fiscal year would end in Sep 30 2026, Medifast Inc 's annual Revenue decline would be -30.08% year on year to $299 millions.

In the Consumer Non Cyclical sector 152 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2932 to 3560.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Food Processing Industry # 42
Consumer Non Cyclical Sector # 153
Overall # 3560

Revenue TTM Y/Y Growth Statistics
High Average Low
72.45 %
 5.99 %
-44.68 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 139
S&P 500 # 3245
Cumulative Revenue growth Comment
Medifast Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Jun 30 2026. If the fiscal year would end in Sep 30 2026, Medifast Inc 's annual Revenue drop would be -30.08% year on year to $299 millions.

In the Consumer Non Cyclical sector 152 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2932 to 3560.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Food Processing Industry # 42
Consumer Non Cyclical Sector # 153
Overall # 3560

Revenue TTM Y/Y Growth Statistics
High Average Low
72.45 %
5.99 %
-44.68 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 42
Sector # 139
S&P 500 # 3245




Other Revenue Growth
Food Processing Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MED's Revenue Growth Ratio versus Food Processing Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Sep 30 2026 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Ingredion Incorporated-1.32%$ -1.322 millions
Coty Inc -1.37%$ -1.370 millions
Tootsie Roll Industries Inc-1.44%$ -1.440 millions
Kraft Heinz Co-1.96%$ -1.956 millions
Utz Brands Inc -2.04%$ -2.043 millions
Pilgrim s Pride Corporation-2.21%$ -2.210 millions
The Marzetti Company-2.29%$ -2.292 millions
The Boston Beer Company Inc -3.24%$ -3.236 millions
Sanfilippo John B and Son Inc-3.53%$ -3.531 millions
Brightview Holdings Inc -3.71%$ -3.710 millions
Beyond Meat Inc -6.79%$ -6.790 millions
Vital Farms Inc -7.98%$ -7.980 millions
Smithfield Foods Inc -8.27%$ -8.273 millions
American Vanguard Corporation-9.09%$ -9.091 millions
Ispire Technology Inc-9.25%$ -9.253 millions
Mgp Ingredients Inc -9.60%$ -9.600 millions
Biote Corp -9.64%$ -9.638 millions
Edgewell Personal Care Company-9.88%$ -9.885 millions
Mosaic Co-10.16%$ -10.161 millions
Cvr Partners Lp-10.64%$ -10.637 millions
Mannatech Inc-12.02%$ -12.023 millions
Westrock Coffee Company-15.29%$ -15.294 millions
Natural Health Trends Corp -15.88%$ -15.878 millions
Tofutti Brands Inc -18.76%$ -18.762 millions
Medifast Inc -19.19%$ -19.192 millions
Niagen Bioscience Inc -19.99%$ -19.991 millions
Trulieve Cannabis Corp.-20.12%$ -20.116 millions
Natural Alternatives International Inc-24.80%$ -24.804 millions
The Hain Celestial Group Inc -29.25%$ -29.251 millions
Upexi Inc -62.29%$ -62.292 millions


About Medifast Inc Revenue Growth Rates (MED), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Medifast Inc (CIK 910329).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-067165
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Medifast Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.